Open-Label Extension and Safety Study of Talazoparib

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 8, 2016

Primary Completion Date

July 20, 2021

Study Completion Date

July 20, 2021

Conditions
Cancer
Interventions
DRUG

Talazoparib

Maximum starting dose: 1mg/day or last tolerated dose in the originating protocol

Trial Locations (38)

1062

Magyar Honvedseg Egeszsegugyi Kozpont, Onkologiai Osztaly, Budapest

13273

Institut Paoli-Calmettes, Marseille

32806

Orlando Health, Inc., Orlando

33028

Memorial Hospital West, Pembroke Pines

46202

Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis

Investigational Drug Senvices, Indianapolis

IU Health University Hospital, Indianapolis

46804

Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne

46845

Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne

47403

IU Health Bloomington Hospital, Bloomington

48109

University of Michigan Health System, Ann Arbor

48201

Karmanos Cancer Institute, Detroit

77030

The University of Texas MD Anderson Cancer Center, Houston

90095

(IRB# 16-001189) Ronald Reagan UCLA Medical Center, Drug Information Center, Los Angeles

TRIO-US Central Administration, Los Angeles

UCLA Hematology/Oncology, Los Angeles

UCLA West Medical Pharmacy, Attn: Steven L. Wong, Pharm.D., Los Angeles

90404

UCLA Hematology/Oncology - Santa Monica, Santa Monica

90505

UCLA Torrance Oncology, Torrance

91054

Frauenklinik des Universitaetsklinikums Erlangen, Erlangen

91105

UCLA Hematology/Oncology - Pasadena, Pasadena

91326

UCLA Hematology/Oncology - Porter Ranch, Porter Ranch

91355

UCLA Hematology/Oncology - Santa Clarita, Valencia

91505

UCLA Hematology/Oncology - Burbank, Burbank

91801

UCLA Hematology/Oncology - Alhambra, Alhambra

92835

St. Jude Hospital Yorba Linda DBA St. Joseph Heritage Healthcare, Fullerton

93309

CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center, Bakersfield

119991

"FSBEI HE First Moscow State Medical University n.a. I.M. Sechenov of the MoH of the RF", Moscow

196105

Medical Technologies LLC, Saint Petersburg

90095-7349

UCLA West Medical Pharmacy, Attn: Steven L. Wong, Pharm.D., Los Angeles

08903

Rutgers Cancer Institute of New Jersey, New Brunswick

T6G 1Z2

Cross Cancer Institute, Edmonton

L8L 8E7

Juravinski Cancer Clinic, Hamilton

H3T 1E2

Jewish General Hospital, Montreal

H-1122

"Orszagos Onkologiai Intezet B Belgyogyaszati-Onkologiai Osztaly es Klinikai Farmakologiai Osztaly", Budapest

MD-2025

Arensia Exploratory Medicine, Institutia Medico-Sanitara Publica Institutul Oncologic, Chisinau

02-801

Szpital Lux Med, Warsaw

SM2 5PT

Royal Marsden NHS Foundation Trust, Sutton

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Medivation, Inc.

INDUSTRY

lead

Pfizer

INDUSTRY